Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation

Background. Catheter pulmonary vein isolation (PVI) is the main interventional procedure for treatment of atrial fibrillation (AF). Recurrences of arrhythmia paroxysms in the postoperative period are mainly determined by reconnection of conduction from the pulmonary veins. However, non-pulmonary vei...

Full description

Bibliographic Details
Main Authors: Yu. S. Krivosheev, D. I. Bashta, A. A. Simonyan, N. A. Tihonova, K. V. Modnikov, T. A. Myznikova, Z. A. Mishodzheva, V. N. Kolesnikov
Format: Article
Language:English
Published: Meshalkin National Medical Research Center 2018-11-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:http://dx.doi.org/10.21688/1681-3472-2018-3-39-48
_version_ 1827851653730009088
author Yu. S. Krivosheev
D. I. Bashta
A. A. Simonyan
N. A. Tihonova
K. V. Modnikov
T. A. Myznikova
Z. A. Mishodzheva
V. N. Kolesnikov
author_facet Yu. S. Krivosheev
D. I. Bashta
A. A. Simonyan
N. A. Tihonova
K. V. Modnikov
T. A. Myznikova
Z. A. Mishodzheva
V. N. Kolesnikov
author_sort Yu. S. Krivosheev
collection DOAJ
description Background. Catheter pulmonary vein isolation (PVI) is the main interventional procedure for treatment of atrial fibrillation (AF). Recurrences of arrhythmia paroxysms in the postoperative period are mainly determined by reconnection of conduction from the pulmonary veins. However, non-pulmonary vein triggers and a positive vagal response of ganglionated plexi (GP) to high frequency stimulation after PVI confirmed by drug testing may affect the long-term efficacy of catheter AF ablation. Aim. To evaluate the efficacy of PVI isolation after drug testing and a negative response to high-frequency stimulation and a positive response to high-frequency stimulation but without subsequent ablation in patients with paroxysmal AF, as well as the efficacy of PVI confirmed by drug testing in patients having nonpulmonary vein triggers. Methods. The present analysis is a part of the randomized study on the comparison of PVI confirmed by drug testing with the absence of non-pulmonary vein triggers and a positive response of GP to high-frequency stimulation with and without GP ablation. PVI was performed in 311 patients. Ninety-six patients were excluded because they required additional GP ablation. Two hundred and fourteen patients were divided into three groups: PVI with a positive GP response (posGP) to high-frequency stimulation without GP ablation (group I, n = 97), PVI with a negative GP response (negGP) to high-frequency stimulation (group II, n = 79) and PVI with non-pulmonary vein triggers (group III, n = 38). The primary endpoint of the study was the freedom from any atrial tachyarrhythmias after 12 months of follow-up confirmed by 24-hour Holter monitoring. The secondary endpoints included the frequency of detecting dormant pulmonary vein conduction, non-pulmonary vein triggers, negative GP response to high-frequency stimulation after catheter PVI. The patients were followed 3, 6, 9, 12 months after the ablation procedure. Results. At the end of the follow-up 57 (72.2%) patients in the PVI + negGP group (group II), 58 (59.8%) patients in the PVI + posGP group (group I) and 20 (52.6%) patients in the PVI + NPT (group III) were free from any atrial tachyarrhythmia (р=0.07; log-rank test). A statistical significance in the efficacy was observed when group II was compared with group III (72.2% and 52.6%, р = 0.028, log-rank test). In the course of primary ablation following PVI, when performing drug testing, dormant atriovenous conduction sites were observed in 105 (33.8%) patients, while non-pulmonary vein triggers (n = 79) were recorded in 38 (12.2%) patients. The frequency of negative GP responses to high-frequency stimulation after PVI accounted for 28.3%. Conclusion. Pulmonary vein isolation confirmed by drug testing, without a response of GP to high-frequency stimulation tends to provide higher efficacy in maintaining the sinus rhythm as compared with PVI and a positive GP response to high-frequency stimulation, but without a statistical significance, whereas nonpulmonary vein triggers after PVI are associated with lower efficacy in the long-term follow-up.
first_indexed 2024-03-12T10:35:57Z
format Article
id doaj.art-c9193e627a074a3db91177ca0eb4dab1
institution Directory Open Access Journal
issn 1681-3472
2500-3119
language English
last_indexed 2024-03-12T10:35:57Z
publishDate 2018-11-01
publisher Meshalkin National Medical Research Center
record_format Article
series Патология кровообращения и кардиохирургия
spelling doaj.art-c9193e627a074a3db91177ca0eb4dab12023-09-02T08:42:56ZengMeshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192018-11-01223394810.21688/1681-3472-2018-3-39-48Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillationYu. S. Krivosheev 0D. I. Bashta1A. A. Simonyan2N. A. Tihonova3K. V. Modnikov4T. A. Myznikova5Z. A. Mishodzheva6V. N. Kolesnikov7Stavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationStavropol Regional Cardiology Hospital, Stavropol, Russian FederationBackground. Catheter pulmonary vein isolation (PVI) is the main interventional procedure for treatment of atrial fibrillation (AF). Recurrences of arrhythmia paroxysms in the postoperative period are mainly determined by reconnection of conduction from the pulmonary veins. However, non-pulmonary vein triggers and a positive vagal response of ganglionated plexi (GP) to high frequency stimulation after PVI confirmed by drug testing may affect the long-term efficacy of catheter AF ablation. Aim. To evaluate the efficacy of PVI isolation after drug testing and a negative response to high-frequency stimulation and a positive response to high-frequency stimulation but without subsequent ablation in patients with paroxysmal AF, as well as the efficacy of PVI confirmed by drug testing in patients having nonpulmonary vein triggers. Methods. The present analysis is a part of the randomized study on the comparison of PVI confirmed by drug testing with the absence of non-pulmonary vein triggers and a positive response of GP to high-frequency stimulation with and without GP ablation. PVI was performed in 311 patients. Ninety-six patients were excluded because they required additional GP ablation. Two hundred and fourteen patients were divided into three groups: PVI with a positive GP response (posGP) to high-frequency stimulation without GP ablation (group I, n = 97), PVI with a negative GP response (negGP) to high-frequency stimulation (group II, n = 79) and PVI with non-pulmonary vein triggers (group III, n = 38). The primary endpoint of the study was the freedom from any atrial tachyarrhythmias after 12 months of follow-up confirmed by 24-hour Holter monitoring. The secondary endpoints included the frequency of detecting dormant pulmonary vein conduction, non-pulmonary vein triggers, negative GP response to high-frequency stimulation after catheter PVI. The patients were followed 3, 6, 9, 12 months after the ablation procedure. Results. At the end of the follow-up 57 (72.2%) patients in the PVI + negGP group (group II), 58 (59.8%) patients in the PVI + posGP group (group I) and 20 (52.6%) patients in the PVI + NPT (group III) were free from any atrial tachyarrhythmia (р=0.07; log-rank test). A statistical significance in the efficacy was observed when group II was compared with group III (72.2% and 52.6%, р = 0.028, log-rank test). In the course of primary ablation following PVI, when performing drug testing, dormant atriovenous conduction sites were observed in 105 (33.8%) patients, while non-pulmonary vein triggers (n = 79) were recorded in 38 (12.2%) patients. The frequency of negative GP responses to high-frequency stimulation after PVI accounted for 28.3%. Conclusion. Pulmonary vein isolation confirmed by drug testing, without a response of GP to high-frequency stimulation tends to provide higher efficacy in maintaining the sinus rhythm as compared with PVI and a positive GP response to high-frequency stimulation, but without a statistical significance, whereas nonpulmonary vein triggers after PVI are associated with lower efficacy in the long-term follow-up.http://dx.doi.org/10.21688/1681-3472-2018-3-39-48atrial fibrillationdormant conductionhigh frequency stimulationnon-pulmonary vein triggers
spellingShingle Yu. S. Krivosheev
D. I. Bashta
A. A. Simonyan
N. A. Tihonova
K. V. Modnikov
T. A. Myznikova
Z. A. Mishodzheva
V. N. Kolesnikov
Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
Патология кровообращения и кардиохирургия
atrial fibrillation
dormant conduction
high frequency stimulation
non-pulmonary vein triggers
title Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
title_full Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
title_fullStr Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
title_full_unstemmed Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
title_short Catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non-pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
title_sort catheter pulmonary vein isolation with drug testing of dormant conduction and detection of non pulmonary vein triggers and high frequency stimulation of left atrial ganglionated plexi in patients with paroxysmal atrial fibrillation
topic atrial fibrillation
dormant conduction
high frequency stimulation
non-pulmonary vein triggers
url http://dx.doi.org/10.21688/1681-3472-2018-3-39-48
work_keys_str_mv AT yuskrivosheev catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT dibashta catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT aasimonyan catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT natihonova catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT kvmodnikov catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT tamyznikova catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT zamishodzheva catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation
AT vnkolesnikov catheterpulmonaryveinisolationwithdrugtestingofdormantconductionanddetectionofnonpulmonaryveintriggersandhighfrequencystimulationofleftatrialganglionatedplexiinpatientswithparoxysmalatrialfibrillation